651 related articles for article (PubMed ID: 10515009)
1. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2.
Minamide A; Tamaki T; Kawakami M; Hashizume H; Yoshida M; Sakata R
Spine (Phila Pa 1976); 1999 Sep; 24(18):1863-70; discussion 1871-2. PubMed ID: 10515009
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of carriers of bone morphogenetic protein for spinal fusion.
Minamide A; Kawakami M; Hashizume H; Sakata R; Tamaki T
Spine (Phila Pa 1976); 2001 Apr; 26(8):933-9. PubMed ID: 11317116
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Healos/bone marrow to INFUSE(rhBMP-2/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion.
Kraiwattanapong C; Boden SD; Louis-Ugbo J; Attallah E; Barnes B; Hutton WC
Spine (Phila Pa 1976); 2005 May; 30(9):1001-7; discussion 1007. PubMed ID: 15864149
[TBL] [Abstract][Full Text] [Related]
4. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate.
Boden SD; Martin GJ; Morone MA; Ugbo JL; Moskovitz PA
Spine (Phila Pa 1976); 1999 Jun; 24(12):1179-85. PubMed ID: 10382242
[TBL] [Abstract][Full Text] [Related]
5. Lumbar spinal fusion with a mineralized collagen matrix and rhBMP-2 in a rabbit model.
Liao SS; Guan K; Cui FZ; Shi SS; Sun TS
Spine (Phila Pa 1976); 2003 Sep; 28(17):1954-60. PubMed ID: 12973141
[TBL] [Abstract][Full Text] [Related]
6. The effects of bone morphogenetic protein and basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion.
Minamide A; Yoshida M; Kawakami M; Okada M; Enyo Y; Hashizume H; Boden SD
Spine (Phila Pa 1976); 2007 May; 32(10):1067-71. PubMed ID: 17471086
[TBL] [Abstract][Full Text] [Related]
7. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate.
Suh DY; Boden SD; Louis-Ugbo J; Mayr M; Murakami H; Kim HS; Minamide A; Hutton WC
Spine (Phila Pa 1976); 2002 Feb; 27(4):353-60. PubMed ID: 11840099
[TBL] [Abstract][Full Text] [Related]
8. Experimental spinal fusion with recombinant human bone morphogenetic protein-2.
Schimandle JH; Boden SD; Hutton WC
Spine (Phila Pa 1976); 1995 Jun; 20(12):1326-37. PubMed ID: 7676329
[TBL] [Abstract][Full Text] [Related]
9. Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2.
Itoh H; Ebara S; Kamimura M; Tateiwa Y; Kinoshita T; Yuzawa Y; Takaoka K
Spine (Phila Pa 1976); 1999 Jul; 24(14):1402-5. PubMed ID: 10423783
[TBL] [Abstract][Full Text] [Related]
10. Radiographic, biomechanical, and histological evaluation of rhBMP-2 in a 3-level intertransverse process spine fusion: an ovine study.
Toth JM; Wang M; Lawson J; Badura JM; DuBose KB
J Neurosurg Spine; 2016 Dec; 25(6):733-739. PubMed ID: 27367941
[TBL] [Abstract][Full Text] [Related]
11. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates.
Barnes B; Boden SD; Louis-Ugbo J; Tomak PR; Park JS; Park MS; Minamide A
Spine (Phila Pa 1976); 2005 May; 30(10):1127-33. PubMed ID: 15897825
[TBL] [Abstract][Full Text] [Related]
12. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
[TBL] [Abstract][Full Text] [Related]
13. Effect of nano-hydroxyapatite/collagen composite and bone morphogenetic protein-2 on lumbar intertransverse fusion in rabbits.
Sun TS; Guan K; Shi SS; Zhu B; Zheng YJ; Cui FZ; Zhang W; Liao SS
Chin J Traumatol; 2004 Feb; 7(1):18-24. PubMed ID: 14728813
[TBL] [Abstract][Full Text] [Related]
14. Purified bovine BMP extract and collagen for spine arthrodesis: preclinical safety and efficacy.
Damien CJ; Grob D; Boden SD; Benedict JJ
Spine (Phila Pa 1976); 2002 Aug; 27(16 Suppl 1):S50-8. PubMed ID: 12205421
[TBL] [Abstract][Full Text] [Related]
15. Early-term and mid-term histologic events during single-level posterolateral intertransverse process fusion with rhBMP-2/collagen carrier and a ceramic bulking agent in a nonhuman primate model: implications for bone graft preparation.
Khan SN; Toth JM; Gupta K; Glassman SD; Gupta MC
J Spinal Disord Tech; 2014 Jun; 27(4):212-9. PubMed ID: 23073151
[TBL] [Abstract][Full Text] [Related]
16. The use of cultured bone marrow cells in type I collagen gel and porous hydroxyapatite for posterolateral lumbar spine fusion.
Minamide A; Yoshida M; Kawakami M; Yamasaki S; Kojima H; Hashizume H; Boden SD
Spine (Phila Pa 1976); 2005 May; 30(10):1134-8. PubMed ID: 15897826
[TBL] [Abstract][Full Text] [Related]
17. Video-assisted lateral intertransverse process arthrodesis. Validation of a new minimally invasive lumbar spinal fusion technique in the rabbit and nonhuman primate (rhesus) models.
Boden SD; Moskovitz PA; Morone MA; Toribitake Y
Spine (Phila Pa 1976); 1996 Nov; 21(22):2689-97. PubMed ID: 8961457
[TBL] [Abstract][Full Text] [Related]
18. Experimental study of carriers of bone morphogenetic protein used for spinal fusion.
Minamide A; Kawakami M; Hashizume H; Sakata R; Yoshida M; Tamaki T
J Orthop Sci; 2004; 9(2):142-51. PubMed ID: 15045542
[TBL] [Abstract][Full Text] [Related]
19. Reversing the inhibitory effect of nicotine on spinal fusion using an osteoinductive protein extract.
Silcox DH; Boden SD; Schimandle JH; Johnson P; Whitesides TE; Hutton WC
Spine (Phila Pa 1976); 1998 Feb; 23(3):291-6; discussion 297. PubMed ID: 9507615
[TBL] [Abstract][Full Text] [Related]
20. Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion.
Sandhu HS; Kanim LE; Kabo JM; Toth JM; Zeegen EN; Liu D; Delamarter RB; Dawson EG
Spine (Phila Pa 1976); 1996 Sep; 21(18):2115-22. PubMed ID: 8893436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
